23. Cellular mechanism of carbi-dopa in treatment of Parkinson's disease ?
(A) Enhance L-dopa absorption in GI tract
(B) Increase the dopamine binding to dopamine D1 receptor
(C) Reduce glutamate inhibition on central dopamine activity
(D) Suppress peripheral dopa decarboxylase activity
阿摩線上測驗
登入